Use of tumor necrosis factor (TNF) as an adjuvant
US4963354A · kind A · utility
66Cited by
8References
8Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 21, 1987 |
| Grant date | Oct 16, 1990 |
| Priority date | — |
| Expiry date | Jan 21, 2007 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2039/55522
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Tumor necrosis factors, alone or together with cytokines such as IL-1 or INF-.gamma., are capable of serving as non-toxic vaccine adjuvants.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.